» Articles » PMID: 36067987

Subacute Thyroiditis After COVID-19: A Literature Review

Overview
Specialty Tropical Medicine
Date 2022 Sep 6
PMID 36067987
Authors
Affiliations
Soon will be listed here.
Abstract

Subacute thyroiditis (SAT), potentially caused by severe acute respiratory syndrome coronavirus 2 infection, has been reported as a complication of COVID-19 since 2020. The clinical characteristics and outcomes of SAT after COVID-19 remain incompletely defined. Therefore, we aimed to collect and survey case reports of SAT after COVID-19. We performed a systematic search of PubMed/MEDLINE, Web of Science, and Google Scholar. The keywords and MeSH terms used for the searches were "subacute thyroiditis" and "COVID-19." A total of 38 patients from 26 case reports, case series, and letters on SAT associated with COVID-19 were included and analyzed. The most frequent SAT symptom was neck pain (27 cases), followed by fever (22 cases). Of the 25 cases with information on the duration between onset of COVID-19 symptoms and onset of SAT symptoms, the shortest was simultaneous occurrence, and the longest was 4 months. In most cases, patients developed SAT at several days or weeks after the onset of COVID-19. All patients with SAT recovered with no severe complications or sequelae. Clinicians should be aware of the possibility of SAT development in patients with neck pain and fever following COVID-19. Further research is necessary to determine the relationship between SAT and COVID-19.

Citing Articles

Proteomics unveil candidate biomarkers and pathogenesis of subacute thyroiditis.

Ran L, Liu X, Tian Y, Zhu J, Gong Z, Qiao Q Endocr Connect. 2025; 14(3).

PMID: 39807704 PMC: 11825159. DOI: 10.1530/EC-24-0535.


Subacute thyroiditis after receiving the COVID-19 vaccine.

Zhong Y, Di C, Yang X, Yu Y Respir Med Case Rep. 2024; 51:102096.

PMID: 39319338 PMC: 11419930. DOI: 10.1016/j.rmcr.2024.102096.


The co-occurrence of SAT, hypophysitis, and Schnitzler syndrome after COVID-19 vaccination: the first described case.

Szklarz M, Gontarz-Nowak K, Kieronski A, Golon K, Gorny J, Matuszewski W Hormones (Athens). 2024; 23(4):735-752.

PMID: 38775985 PMC: 11519144. DOI: 10.1007/s42000-024-00567-6.


Neck Pain and Symptomatic Hypothyroidism: An Atypical Presentation of Subacute Thyroiditis.

Mitchell M, Shults D, Gonzalez E Cureus. 2024; 16(4):e58148.

PMID: 38741869 PMC: 11088989. DOI: 10.7759/cureus.58148.


Inflammatory and Infectious Disorders in Endocrine Pathology.

Uccella S, Dottermusch M, Erickson L, Warmbier J, Montone K, Saeger W Endocr Pathol. 2023; 34(4):406-436.

PMID: 37209390 PMC: 10199304. DOI: 10.1007/s12022-023-09771-3.


References
1.
Mattar S, Koh S, Rama Chandran S, Cherng B . Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020; 13(8). PMC: 7449350. DOI: 10.1136/bcr-2020-237336. View

2.
Mathews S, Castellanos-Diaz J, Srihari A, Kadiyala S, Leey-Casella J, Ghayee H . Subacute Thyroiditis and Heart Failure in a Patient Presenting With COVID-19. J Investig Med High Impact Case Rep. 2021; 9:23247096211009412. PMC: 8056563. DOI: 10.1177/23247096211009412. View

3.
Chakraborty U, Ghosh S, Chandra A, Ray A . Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity. BMJ Case Rep. 2020; 13(12). PMC: 10577769. DOI: 10.1136/bcr-2020-239953. View

4.
Taquet M, Luciano S, Geddes J, Harrison P . Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2020; 8(2):130-140. PMC: 7820108. DOI: 10.1016/S2215-0366(20)30462-4. View

5.
Brancatella A, Ricci D, Cappellani D, Viola N, Sgro D, Santini F . Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series. J Clin Endocrinol Metab. 2020; 105(10). PMC: 7454668. DOI: 10.1210/clinem/dgaa537. View